Kim K, Li J, Barazia A, Tseng A, Youn S-W, Abbadessa G, Yu Y, Schwartz B, Andrews RK, Gordeuk VR, Cho J. ARQ 092, an orally-available, selective AKT inhibitor, attenuates neutrophil-platelet interactions in sickle cell disease. Haematologica [Internet]. 2017Jan.31 [cited 2026Nov.4];102(2):246-59. Available from: https://haematologica.org/article/view/7965